Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Dec 6, 2023; 11(34): 8139-8146
Published online Dec 6, 2023. doi: 10.12998/wjcc.v11.i34.8139
Table 5 Changes in the renal and bone safety parameters from baseline to week 48
Variable
ETV group (n = 30)
TAF group (n = 30)
P value
eGFR (mL/min/1.73 m2)-1.3 ± 3.2-1.5 ± 2.90.76
Serum creatinine (μmol/L)1.7 ± 5.62.1 ± 4.80.67
UPCR (mg/mmol)-0.2 ± 0.6-0.1 ± 0.50.58
BMD at lumbar spine (%)-2.1 ± 1.4-0.8 ± 1.20.004
BMD at hip (%)-1.8 ± 1.3-0.6 ± 1.10.007
Serum calcium (mmol/L)-0.01 ± 0.05-0.02 ± 0.040.42
Serum phosphate (mmol/L)-0.03 ± 0.12-0.04 ± 0.110.69
Serum alkaline phosphatase (U/L)-3.7 ± 12.4-4.3 ± 11.60.79
Serum parathyroid hormone (pg/mL)-2.4 ± 8.7-3.1 ± 9.20.68